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KNEE OSTEOARTHRITIS PROGRESSION DURING 6 YEARS
FOLLOW-UP: THE PROGNOSTIC VALUE OF BONE AND
CARTILAGE BIOMARKERS
J. Kumm1, A. Tamm1, M. Lintrop2, A. Tamm1
1Univ. of Tartu, Tartu, Estonia; 2Tartu Univ. Clinics, Tartu, Estonia
Purpose: To investigate the prognostic value of bone-cartilage
biomarkers in predicting knee OA progression during 6 years
follow-up.
Methods: A population cohort aged 35-55 years (n=141) was
investigated at baseline and after 3 and 6 years follow-up.
Tibiofemoral (TF) and patellofemoral (PF) radiographs were
graded for OA. Progression was documented if presence of os-
teophytes and/or joint space narrowing (JSN) was described in
subjects with no previous radiographic changes or in case of
radiographic deterioration during 6 years. At baseline and at 3
years follow-up, biomarkers of bone resorption (CTx-I), - formation
(PINP), osteocalcin (OC) were assessed by ECLIA and cartilage
oligomeric matrix protein (COMP) - by ELISA. Speciﬁc markers
of cartilage degradation (U-CTx-II) and synthesis (PIIANP) were
assayed by ELISA only at 3-years follow-up. For statistics non-
parametric methods were used.
Results: Within 6 years follow-up, progression in TF joint was
observed in 38% of cases, mostly from OA grade 0 to 1. At 3
years follow-up we documented radiographic OA progression in
16 men and 38 women out of 141, and at 6 years follow-up in
21 men and 49 women out of 131. In women, the progression
in TF osteophytes during 6 year follow-up was related to higher
levels of COMP compared to non-progressors (p=0.011). The
higher COMP, OC and U-CTx-II levels in case of TF osteophyte
progression was found already at 3 years follow-up.
The women who developed TF JSN progression had lower PINP
and higher PIIANP levels compared to non-progressors (p levels
0.030 and 0.031, respectively). Progression in PF JSN was related
to higher COMP and U-CTx-II values (p levels 0.047 and 0.003,
respectively). Increased U-CTx-II levels was found in women who
had progression in TFOA and PFOA simultaneously (p=0.030).
Baseline PINP levels were higher in those who developed TFOA
and PFOA during 6 years follow-up (p=0.007). Baseline CTx-I
levels were higher in case of PF osteophyte progression (p=0.037).
In men, the progression in TF and PF osteophytes was related to
higher levels of COMP (p levels 0.003 and 0.025, respectively).
The progression in PF osteophytes during 6 years was related to
the increase in PIIANP (p=0.019). The progression in JSN was
associated with lower OC levels (p=0.045).
Conclusions:
• The 6 years follow-up demonstrated changes in radiographic
stage as well as in the levels of the set of biomarkers.
• The pattern of biomarkers differed by gender.
• In both genders, S-COMP levels that reﬂect the status of several
soft joint tissues was associated with the development of TF
osteophytes.
• In women, increased degradation of articular cartilage based
on U-CTx-II associated with progression in PF JSN. The same
process was found in cases when TFOA and PFOA progression
was combined.
• Increased synthesis of articular cartilage based on S-PIIANP
was related to progression in TF JSN that might refer to en-
hanced reparative process.
• The activation of bone metabolism was demonstrated in future
knee OA progressors already at baseline by the increase in
osteoblast-related biomarkers S-OC and S-PINP.
This study is supported by ECTS/Czech Society Young Investigator
Grant.
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SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN
(COMP) AND INCIDENT AND PROGRESSIVE
RADIOGRAPHIC OSTEOARTHRITIS: THE JOHNSTON
COUNTY OSTEOARTHRITIS PROJECT
Y.M. Golightly1, A.E. Nelson1, V.B. Kraus2, T. Stabler2,
J.B. Renner3, J.M. Jordan1
1Thurston Arthritis Res. Ctr., Univ. of North Carolina, Chapel Hill,
NC; 2Duke Univ. Med. Ctr., Durham, NC; 3Dept. of Radiology,
Univ. of North Carolina, Chapel Hill, NC
Purpose: In our prior cross-sectional analyses, elevated serum
cartilage oligomeric matrix protein (COMP) levels were associ-
ated with the presence and severity of knee and knee plus hip
radiographic osteoarthritis (rOA). This analysis longitudinally ex-
amines the usefulness of serum COMP as a predictor of incident
and progressive knee and hip rOA in a subsample of a bi-racial
county-based population.
Methods: Baseline serum COMP levels were available for 802
participants in the Johnston County Osteoarthritis Project. Serum
COMP was measured using an in-house sandwich enzyme linked
immunosorbent assay with 5.8-6.6% intra-assay variability and
8.7-9.7% inter-assay variability. Paired baseline and follow-up ﬁlms
for the knee and hip were available for 359 and 338 individuals,
respectively. Incident rOA was deﬁned as: 1) development of K-
L grade ≥2 in a joint with K-L grade <2 at baseline, and 2)
development of K-L grade ≥1 in a joint with K-L grade=0 at
baseline. Progression of rOA was deﬁned as: 1) an increase by
≥1 K-L grade in a joint that was a K-L grade ≥2 at baseline, and
2) an increase by ≥1 K-L grade in a joint that was a K-L grade ≥1
at baseline. Incident osteophytes (OST) and joint space narrowing
(JSN) were identiﬁed in a joint with an OST or JSN grade of 0
at baseline and ≥1 at follow-up. Progressive OST and JSN was
deﬁned as at least 1 grade increase in a joint with an OST or
JSN grade ≥1 at baseline. The natural logarithm transformation of
COMP (lnCOMP) was used to produce a near-normal distribution
for analyses. Multivariable Weibull regression models (accounting
for varying follow-up times) were used to provide hazard ratios
(HR) for each one-unit increase in lnCOMP with rOA outcomes,
clustering by individual.
Results: Among participants with paired ﬁlm and COMP data,
mean age was 61.6 (± 9.7) years, mean body mass index was
30.3 (± 6.8) kg/m2, 62.7% were female, and 43.5% were African
American. Mean serum COMP was 1059.8 (±600.8) ng/ml (range
170.3-4634.9 ng/ml). Mean time of follow-up was 6.2 (±1.4) years
(range 3-10 years). In unadjusted models, higher lnCOMP was
associated with an increased HR of nearly 60% for incidence
of knee JSN (HR= 1.59, 95% conﬁdence interval [CI] 0.98-2.58,
p=0.06) and approximately 90% for incidence of hip JSN (HR=
1.88, 95% CI 0.99-3.57, p=0.06). Associations were not statistically
signiﬁcant after adjusting for age, body mass index, gender, and
race (knee JSN: adjusted HR= 1.31, 95% CI 0.75-2.30; hip JSN:
adjusted HR= 2.03, 95% CI 0.90-4.58). No statistically signiﬁcant
associations were noted for other incident or progressive rOA knee
and hip outcomes. No interactions of lnCOMP with race or gender
were observed in any model (p >0.10).
Conclusions: Higher serum COMP may be associated with in-
cident knee and hip rOA, particularly with incident JSN, but the
association may be inﬂuenced by other risk factors. No association
was observed with progression of knee or hip rOA.
